A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

• Status: Completed
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and efficacy study of abicipar pegol in patients with diabetic macular edema.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Ranibizumab

Criteria

Inclusion Criteria:

• Diagnosis of diabetes mellitus (Type 1 or 2)

• Decreased vision due to diabetic macular edema in at least 1 eye

• Best corrected visual acuity of 20/32 to 20/320 in the study eye and 20/200 or better in the fellow eye

Exclusion Criteria:

• Stroke or heart attack within the past 3 months

• History of vitrectomy, macular surgery, or glaucoma surgery in the study eye

• Cataract or refractive surgery in the study eye within the last 3 months

• Laser photocoagulation of the study eye within the last 3 months